The purpose of this Clinical Investigator Development Award is to prepare the applicant for a career as an independent investigator in cardiology. The applicant has developed a great interest in the cellular dysfunction observed in heart failure. As a Ph.D. student, the PI has closely examined the role of P-adrenergic receptor function and calcium handling in animal models of hypertrophy and heart failure as well as in single myocytes isolated from failing and non-failing human hearts. The applicant proposes to acquire additional skills in biophysics and molecular biology in the context of a project that builds on her experience on somatic gene transfer and contractile dysfunction in failing cardiac myocytes. Congestive heart failure has reached epidemic proportions in the United States. One of the key abnormalities in human heart failure is a defect in intracellular Ca2 handling associated with abnormal Ca2 reuptake into the sarcoplasmic reticulum (SR) in both human and experimental heart failure. More specifically, deficient Ca2 reuptake has been associated with a decrease in the expression and activity of SR Ca2-ATPase (SERCA2a). The applicant has shown that overexpression of exogenous SERCA2a improves contractility in failing human cardiomyocytes and survival in experimental models of heart failure. However, beyond the decrease in SERCA2a protein expression, the transporter activity was found to be decreased in failing hearts. In addition, changes in card ioprotective proteins that facilitate transport, folding of newly synthesized or refolding of damaged proteins may also occur.
The aims of this proposal are to investigate the structure function relationship of the transporter in failing hearts as well as to examine the family of cardioprotective proteins involved in folding SERCA2a. In this application, we propose to test the following hypotheses: 1) SERCA2a is structurally abnormal contributing to its deficiency in transporting Ca2 in failing hearts and 2) chaperone proteins such as Glucose Related Proteins (GRPs) GRP 78 and 94 may play an important role in the structural integration or repair of SERCA2a in normal and failing hearts. To test these hypotheses, three specific aims are proposed:
In Specific aim 1 : the crystal structure of SERCA2a will be characterized, in specific aim 2: the role of chaperone proteins will be examined through somatic gene transfer in non failing and failing human cardiomyocytes, and in specific aim 3: the role of chaperone proteins will be examined in vitro and in vivo in an animal model of heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL069842-03
Application #
6795852
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F2))
Program Officer
Commarato, Michael
Project Start
2002-09-30
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
3
Fiscal Year
2004
Total Cost
$129,951
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Gianni, Davide; Li, Airong; Tesco, Giuseppina et al. (2010) Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 121:1216-26
Sakata, Susumu; Lebeche, Djamel; Sakata, Yuri et al. (2007) Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Am J Physiol Heart Circ Physiol 292:H1204-7
Sakata, Susumu; Lebeche, Djamel; Sakata, Naoya et al. (2007) Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol 42:852-61
Kuhn, Bernhard; del Monte, Federica; Hajjar, Roger J et al. (2007) Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13:962-9
Sakata, Susumu; Lebeche, Djamel; Sakata, Yuri et al. (2006) Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther 13:987-96
Gorza, Luisa; del Monte, Federica (2005) Protein unfolding in cardiomyopathies. Heart Fail Clin 1:237-50
del Monte, Federica; Kizana, Eddy; Tabchy, Adel et al. (2004) Targeted gene transfer in heart failure: implications for novel gene identification. Curr Opin Mol Ther 6:381-94
Lebeche, Djamel; Kaprielian, Roger; del Monte, Federica et al. (2004) In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110:3435-43
Boecker, Wolfgang; Bernecker, Oliver Y; Wu, Joseph C et al. (2004) Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging 3:69-75